ArticleDiabetes & metabolism journal2023

Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing Surveillance.

Jun Sung Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.